Turkish Pharma Outlook 2018: Growth Tempered By Lira Devaluation And Pricing Policies
Executive Summary
Turkey's pharmaceutical market is likely to grow by around 12-15% this year, but tight pricing policies and a low fixed exchange rate for the euro at a time when the Turkish lira is volatile and weak against both the euro and US dollar spell trouble for the industry.